Andres M Kanner Selected Research

Oxcarbazepine (Trileptal)

1/2022	Antiseizure Medications for Adults With Epilepsy: A Review.
10/2018	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
10/2018	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
7/2018	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
7/2018	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
5/2004	Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andres M Kanner Research Topics

Disease

51	Epilepsy (Aura) 01/2022 - 03/2002
16	Seizures (Absence Seizure) 06/2019 - 03/2002
6	Partial Epilepsies (Epilepsy, Partial) 01/2022 - 05/2013
6	Generalized Epilepsy 10/2018 - 05/2004
5	Mood Disorders (Mood Disorder) 01/2022 - 05/2005
5	Mental Disorders (Mental Disorder) 01/2022 - 03/2002
4	Depressive Disorder (Melancholia) 01/2022 - 05/2005
4	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 03/2002
4	Drug Resistant Epilepsy 07/2008 - 08/2003
3	Migraine Disorders (Migraine) 01/2022 - 03/2002
3	Epileptic Syndromes 01/2022 - 03/2002
3	Juvenile Myoclonic Epilepsy 10/2018 - 09/2015
3	Anxiety Disorders (Anxiety Disorder) 01/2017 - 06/2012
2	Temporal Lobe Epilepsy 01/2022 - 10/2017
2	Absence Epilepsy (Childhood Absence Epilepsy) 10/2018 - 07/2018
2	Status Epilepticus (Complex Partial Status Epilepticus) 07/2008 - 05/2008
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2020
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Lennox Gastaut Syndrome 10/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Hemianopsia (Bitemporal Hemianopsia) 10/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017
1	Pain (Aches) 09/2015
1	Cognitive Dysfunction 09/2015
1	Sudden Unexpected Death in Epilepsy 09/2015
1	Obesity 09/2015
1	Hyperammonemia 11/2007
1	Sleep Wake Disorders 09/2006
1	Dementia (Dementias) 09/2006
1	Movement Disorders (Movement Disorder) 09/2006
1	Stroke (Strokes) 09/2006
1	Exanthema (Rash) 09/2005

Drug/Important Bio-Agent (IBA)

27	Anticonvulsants (Antiepileptic Drugs)IBA 10/2018 - 03/2002
11	Antidepressive Agents (Antidepressants)IBA 12/2020 - 04/2002
9	Pharmaceutical PreparationsIBA 01/2022 - 08/2004
7	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022 - 05/2004
6	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 05/2004
6	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2022 - 05/2004
6	Valproic Acid (Depakote)FDA LinkGeneric 10/2018 - 03/2002
6	Topiramate (Topamax)FDA LinkGeneric 10/2018 - 05/2004
5	Biological ProductsIBA 01/2022 - 04/2002
5	Zonisamide (Zonegran)FDA LinkGeneric 10/2018 - 05/2004
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 04/2002
5	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2017 - 03/2013
5	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 04/2002
4	eslicarbazepineIBA 10/2018 - 07/2018
4	Lacosamide FDA Link 10/2018 - 07/2018
4	Clobazam (HR 376)IBA 10/2018 - 07/2018
4	Vigabatrin FDA Link 10/2018 - 07/2018
4	rufinamide FDA Link 10/2018 - 07/2018
4	Gabapentin (Neurontin)FDA LinkGeneric 10/2018 - 05/2004
4	Pregabalin (Lyrica)FDA Link 10/2018 - 07/2018
4	ezogabine (retigabine)IBA 10/2018 - 07/2018
4	perampanelIBA 10/2018 - 07/2018
3	Tiagabine (Gabitril)FDA Link 10/2018 - 05/2004
3	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2017 - 03/2013
3	Psychotropic Drugs (Psychoactive Drugs)IBA 07/2008 - 07/2005
2	Central Nervous System StimulantsIBA 12/2020 - 07/2008
2	Felbamate (Felbatol)FDA Link 10/2018 - 07/2018
2	Ethosuximide (Zarontin)FDA LinkGeneric 10/2018 - 07/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2011 - 07/2002
2	Glutamic Acid (Glutamate)FDA Link 09/2011 - 07/2009
2	gamma-Aminobutyric Acid (GABA)IBA 09/2011 - 04/2002
2	Therapeutic UsesIBA 07/2008 - 03/2002
2	Antipsychotic Agents (Antipsychotics)IBA 07/2008 - 08/2004
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	EnzymesIBA 01/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2022
1	Cefepime (Maxipime)FDA LinkGeneric 01/2019
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2018
1	Hypnotics and Sedatives (Sedatives)IBA 01/2017
1	SolutionsIBA 11/2014
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 06/2012
1	Aminobutyrates (Aminobutyric Acid)IBA 09/2011
1	diethylstilbestrol monophosphate (PDES)IBA 10/2010
1	GlucocorticoidsIBA 07/2009
1	phenyl-2-aminoethyl sulfide (PAES)IBA 10/2003
1	Dopamine (Intropin)FDA LinkGeneric 04/2002

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2003
11	Drug Therapy (Chemotherapy) 01/2022 - 05/2005
6	Lasers (Laser) 01/2022 - 01/2017
1	Aftercare (After-Treatment) 06/2019
1	Home Nursing (Nursing, Home) 01/2017
1	Vagus Nerve Stimulation 03/2008
1	Deep Brain Stimulation 11/2004
1	Electrodes (Electrode) 10/2002